Search research articles
Contact Us
Filters
Showing results (71-80 of 353) with videos related to
Page
of 36
Sort By:
American Heart Journal
|
July 22, 2009
The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V
Arman T Askari, Mehdi H Shishehbor, Matthew A Kaminski, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 8, 2006
Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions
John Kao, A Michael Lincoff, Eric J Topol, et al.
The American Journal of Cardiology
|
April 26, 2003
Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations
Leslie Cho, Kandice Kottke-Marchant, A Michael Lincoff, et al.
Journal of Clinical Lipidology
|
December 14, 2025
Lack of impact of adjunctive lipid-modifying therapy in the CLEAR Outcomes trial
Venu Menon, LeAnne Bloedon, Na Li, et al.
The American Journal of Cardiology
|
May 27, 2006
Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy)
James C Blankenship, Tom Haldis, Frederick Feit, et al.
The American Journal of Cardiology
|
December 26, 2015
Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials)
Vivian G Ng, Andreas Baumbach, Liliana Grinfeld, et al.
Circulation
|
August 11, 2004
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention
Sorin J Brener, David J Moliterno, A Michael Lincoff, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis
Haris Riaz, Safi U Khan, Hammad Rahman, et al.
Circulation. Cardiovascular Interventions
|
February 10, 2012
Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
Christopher W Good, Steven R Steinhubl, Danielle M Brennan, et al.
The American Journal of Cardiology
|
October 7, 2004
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy)
Fernando A Cura, Marco Roffi, Narcis Pasca, et al.
Page
of 36
Search research articles
Search
Showing results (71-80 of 353) with videos related to
Sort By:
Page
of 36
American Heart Journal
|
July 22, 2009
The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V
Arman T Askari, Mehdi H Shishehbor, Matthew A Kaminski, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 8, 2006
Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions
John Kao, A Michael Lincoff, Eric J Topol, et al.
The American Journal of Cardiology
|
April 26, 2003
Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations
Leslie Cho, Kandice Kottke-Marchant, A Michael Lincoff, et al.
Journal of Clinical Lipidology
|
December 14, 2025
Lack of impact of adjunctive lipid-modifying therapy in the CLEAR Outcomes trial
Venu Menon, LeAnne Bloedon, Na Li, et al.
The American Journal of Cardiology
|
May 27, 2006
Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy)
James C Blankenship, Tom Haldis, Frederick Feit, et al.
The American Journal of Cardiology
|
December 26, 2015
Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials)
Vivian G Ng, Andreas Baumbach, Liliana Grinfeld, et al.
Circulation
|
August 11, 2004
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention
Sorin J Brener, David J Moliterno, A Michael Lincoff, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis
Haris Riaz, Safi U Khan, Hammad Rahman, et al.
Circulation. Cardiovascular Interventions
|
February 10, 2012
Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
Christopher W Good, Steven R Steinhubl, Danielle M Brennan, et al.
The American Journal of Cardiology
|
October 7, 2004
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy)
Fernando A Cura, Marco Roffi, Narcis Pasca, et al.
Page
of 36